Related references
Note: Only part of the references are listed.Optimization of a fragment linking hit toward Dengue and Zika virus NS5 methyltransferases inhibitors
Jessica Hernandez et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
The Pseudo Natural Product Myokinasib Is a Myosin Light Chain Kinase 1 Inhibitor with Unprecedented Chemotype
Tabea Schneidewind et al.
CELL CHEMICAL BIOLOGY (2019)
Structural Searching of Biosynthetic Enzymes to Predict Protein Targets of Natural Products
Noe Sturm et al.
PLANTA MEDICA (2018)
When fragments link: a bibliometric perspective on the development of fragment-based drug discovery
Angelo K. S. Romasanta et al.
DRUG DISCOVERY TODAY (2018)
NMR Biochemical Assay for Oxidosqualene Cyclase: Evaluation of Inhibitor Activities on Trypanosoma cruzi and Human Enzymes
Osamu Tani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry
Hoan Vu et al.
ACS INFECTIOUS DISEASES (2018)
Chromopynones are pseudo natural product glucose uptake inhibitors targeting glucose transporters GLUT-1 and-3
George Karageorgis et al.
NATURE CHEMISTRY (2018)
Identification of Natural Products as an Inhibitor of β-OG Pocket Binder of Dengue Virus Envelope Protein Using Fragment-Based Drug Design and Molecular Docking Approach
U. S. F. Tambunan et al.
PROCEEDINGS OF THE 3RD INTERNATIONAL SYMPOSIUM ON CURRENT PROGRESS IN MATHEMATICS AND SCIENCES 2017 (ISCPMS2017) (2018)
Combining Ensemble Learning with a Fragment-Based Topological Approach To Generate New Molecular Diversity in Drug Discovery: In Silico Design of Hsp90 Inhibitors
Alejandro Speck-Planche
ACS OMEGA (2018)
Mass spectrometry for fragment screening
Daniel Shiu-Hin Chan et al.
STRUCTURE-BASED DRUG DESIGN: INSIGHTS FROM ACADEMIA AND INDUSTRY (2017)
Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design
Fatiha Benmansour et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Fragment library design, synthesis and expansion: nurturing a synthesis and training platform
Peter C. Ray et al.
DRUG DISCOVERY TODAY (2017)
Exploring Natural Product Fragments for Drug and Probe Discovery
Axel Pahl et al.
CHIMIA (2017)
Fragment-based drug discovery as alternative strategy to the drug development for neglected diseases
Juliana da Fonseca Rezende e Mello et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2017)
Construction of a 3D-shaped, natural product like fragment library by fragmentation and diversification of natural products
Horst Prescher et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Opportunity Knocks: Organic Chemistry for Fragment-Based Drug Discovery (FBDD)
Christopher W. Murray et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Six Biophysical Screening Methods Miss a Large Proportion of Crystallographically Discovered Fragment Hits: A Case Study
Johannes Schiebel et al.
ACS CHEMICAL BIOLOGY (2016)
An NMR Biochemical Assay for Fragment-Based Drug Discovery: Evaluation of an Inhibitor Activity on Spermidine Synthase of Trypanosoma cruzi
Kazuhiko Yamasaki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia
Gyoergy M. Keseru et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Native Mass Spectrometry in Fragment-Based Drug Discovery
Liliana Pedro et al.
MOLECULES (2016)
Counting on natural products for drug design
Tiago Rodrigues et al.
NATURE CHEMISTRY (2016)
Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a
Nagarajan Elumalai et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAP
Gianni Chessari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Chemography of Natural Product Space
Tomoyuki Miyao et al.
PLANTA MEDICA (2015)
Similarity between Flavonoid Biosynthetic Enzymes and Flavonoid Protein Targets Captured by Three-Dimensional Computing Approach
Noe Sturm et al.
PLANTA MEDICA (2015)
Detection of secondary binding sites in proteins using fragment screening
R. Frederick Ludlow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A binding hotspot in Trypanosoma cruzi histidyl-tRNA synthetase revealed by fragment-based crystallographic cocktail screens
Cho Yeow Koh et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2015)
Capturing Nature's Diversity
Mauro Pascolutti et al.
PLOS ONE (2015)
Fragment-Based Screening in Tandem with Phenotypic Screening Provides Novel Antiparasitic Hits
Antoni R. Blaazer et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery
Bruno Coutard et al.
ANTIVIRAL RESEARCH (2014)
Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus
Daniel Reker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Yeast Synthetic Biology Platform Generates Novel Chemical Structures as Scaffolds for Drug Discovery
Jens Klein et al.
ACS SYNTHETIC BIOLOGY (2014)
Fragment-based hit identification: thinking in 3D
Andrew D. Morley et al.
DRUG DISCOVERY TODAY (2013)
Natural-product-derived fragments for fragment-based ligand discovery
Bjoern Over et al.
NATURE CHEMISTRY (2013)
Nonlinear dimensionality reduction and mapping of compound libraries for drug discovery
Michael Reutlinger et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2012)
Serine is a natural ligand and allosteric activator of pyruvate kinase M2
Barbara Chaneton et al.
NATURE (2012)
Structure-guided fragment-based in silico drug design of dengue protease inhibitors
Tim Knehans et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2011)
Route to three-dimensional fragments using diversity-oriented synthesis
Alvin W. Hung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species
Francisco J. Prado-Prado et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Extended-Connectivity Fingerprints
David Rogers et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
ChemGPS-NPWeb: chemical space navigation online
Josefin Rosen et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2009)
Novel Chemical Space Exploration via Natural Products
Josefin Rosen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
One Scaffold, Three Binding Modes: Novel and Selective Pteridine Reductase 1 Inhibitors Derived from Fragment Hits Discovered by Virtual Screening
Chidochangu P. Mpamhanga et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Frank Lovering et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Natural product-likeness score and its application for prioritization of compound libraries
Peter Ertl et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
Scaffold diversity of natural products: inspiration for combinatorial library design
Kristina Grabowski et al.
NATURAL PRODUCT REPORTS (2008)
ChemGPS-NP: Tuned for navigation in biologically relevant chemical space
Josefin Larsson et al.
JOURNAL OF NATURAL PRODUCTS (2007)
Using fragment cocktail crystallography to assist inhibitor design of Trypanosoma brucei nucleoside 2-deoxyribosyltransferase
Jurgen Bosch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A common protein fold topology shared by flavonoid biosynthetic enzymes and therapeutic targets
BM McArdle et al.
JOURNAL OF NATURAL PRODUCTS (2006)
Expanding the ChemGPS chemical space with natural products
J Larsson et al.
JOURNAL OF NATURAL PRODUCTS (2005)
Share Paper
